Change search
ReferencesLink to record
Permanent link

Direct link
A proposed model for prediction of survival based on a follow-up study in unresectable pancreatic cancer.
Blekinge Institute of Technology, School of Health Science.
2013 (English)In: BMJ Open, ISSN 2044-6055, Vol. 3, no 12, 1-6 p.Article in journal (Refereed) Published
Abstract [en]

OBJECTIVES: To define an easy-to-use model for prediction of survival time in patients with unresectable pancreatic cancer in order to optimise patient' care. DESIGN: An observational retrospective study on patients with unresectable pancreatic cancer. The initial radiographs at presentation of symptoms were reviewed and the maximum diameter of the primary tumour was determined. The occurrence of liver metastases and performance status that determines initiation of chemotherapy was also used in the regression analysis to identify prognostic subgroups. SETTING: County hospital in south-east of Sweden. POPULATION: Consecutive patients with unresectable pancreatic cancer who were diagnosed between January 2003 and May 2010 (n=132). MAIN OUTCOME MEASURES: Statistical analyses were performed using Stata V.13. Survival time was assessed with Kaplan-Meier analysis, log-rank test for equality of survivor functions and Cox regression for calculation of individual hazard based on tumour diameter, presence of liver metastases and initiation of chemotherapy treatment according to patient performance status. RESULTS: The individual hazard was log h=0.357 tumour size+1.181 liver metastases-0.989 performance status/chemotherapy. Three prognostic groups could be defined: a low-risk group with a median survival time of 6.7 (IQR 9.7) months, a medium-risk group with a median survival time of 4.5 (IQR 4.5) months and a high-risk group with a median survival time of 1.2 (IQR 1.7) months. CONCLUSIONS: The maximum diameter of the primary tumour and the presence of liver metastases found at the X-ray examination of patients with pancreatic cancer, in conjunction with whether or not chemotherapy is initiated according to performance status, predict the survival time for patients who do not undergo surgical resection. The findings result in an easy-to-use model for predicting the survival time.

Place, publisher, year, edition, pages
BMJ Publishing Group , 2013. Vol. 3, no 12, 1-6 p.
Keyword [en]
Oncology, Surgery
National Category
Medical and Health Sciences
URN: urn:nbn:se:bth-6684DOI: 10.1136/bmjopen-2013-004064.ISI: 000330541400009Local ID: diva2:834208
Open access articleAvailable from: 2014-07-17 Created: 2014-01-09 Last updated: 2015-06-30Bibliographically approved

Open Access in DiVA

fulltext(916 kB)19 downloads
File information
File name FULLTEXT01.pdfFile size 916 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Johansson, Sigrid
By organisation
School of Health Science
In the same journal
BMJ Open
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 19 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 33 hits
ReferencesLink to record
Permanent link

Direct link